MARIMO cells harbor a CALR mutation but are not dependent on JAK2/STAT5 signaling

被引：31
|
作者：
Kollmann, K. [1 ,2 ]
Nangalia, J. [1 ,2 ,3 ,4 ]
Warsch, W. [1 ,2 ]
Quentmeier, H. [5 ]
Bench, A. [4 ]
Boyd, E. [4 ]
Scott, M. [4 ]
Drexler, H. G. [5 ]
Green, A. R. [1 ,2 ,4 ]
机构：
[1] Univ Cambridge, Wellcome Trust MRC Stem Cell Inst, Cambridge Inst Med Res, Cambridge, England
[2] Univ Cambridge, Dept Haematol, Cambridge, England
[3] Wellcome Trust Sanger Inst, Cambridge, England
[4] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England
[5] German Collect Microorganisms & Cell Cultures, Leibniz Inst DSMZ, Braunschweig, Germany
来源：
LEUKEMIA | 2015年 / 29卷 / 02期
关键词：
MYELOPROLIFERATIVE NEOPLASMS; ESSENTIAL THROMBOCYTHEMIA; MYELOFIBROSIS; RETICULUM; JAK2; CALRETICULIN; INHIBITOR;
D O I：
10.1038/leu.2014.285
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：494 / 497
页数：5
相关论文
共 50 条
  • [1] The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytoma
    Keller, Alexandra
    Wingelhofer, Bettina
    Peter, Barbara
    Bauer, Karin
    Berger, Daniela
    Gamperl, Susanne
    Reifinger, Martin
    Cerny-Reiterer, Sabine
    Moriggl, Richard
    Willmann, Michael
    Valent, Peter
    Hadzijusufovic, Emir
    VETERINARY AND COMPARATIVE ONCOLOGY, 2018, 16 (01) : 55 - 68
  • [2] Dual inhibition of Jak2 and STAT5 enhances killing of myeloproliferative neoplasia cells
    Bar-Natan, M.
    Nelson, E. A.
    Walker, S. R.
    Kuang, Y.
    Distel, R. J.
    Frank, D. A.
    LEUKEMIA, 2012, 26 (06) : 1407 - 1410
  • [3] Different CALR mutation subtypes in essential thrombocythemia and primary myelofibrosis patients without JAK2 mutation
    Layla M. Saleh
    Reem Algamal
    Hanaa Abd Elmasseh
    Emily Barber
    Hasan Abdel-ghaffar
    memo - Magazine of European Medical Oncology, 2020, 13 : 235 - 243
  • [4] Different CALR mutation subtypes in essential thrombocythemia and primary myelofibrosis patients without JAK2 mutation
    Saleh, Layla M.
    Algamal, Reem
    Abd Elmasseh, Hanaa
    Barber, Emily
    Abdel-ghaffar, Hasan
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (02) : 235 - 243
  • [5] MicroRNA-101 expression is associated with JAK2V617F activity and regulates JAK2/STAT5 signaling
    Pagano, Francesca
    Comoglio, Federico
    Grinfeld, Jacob
    Li, Juan
    Godfrey, Anna
    Baxter, Joanna
    Silber, Yvonne
    Green, Anthony R.
    LEUKEMIA, 2018, 32 (08) : 1826 - 1830
  • [6] A germline JAK2 exon12 mutation and a late somatic CALR mutation in a patient with essential thrombocythemia
    Hao, Zhuanghui
    Li, Juan
    Gao, Feng
    Ren, Weixiao
    Lu, Xiaomei
    Feng, Jinyi
    Zhang, Chen
    Bian, Sicheng
    Xie, Juan
    Luo, Ming
    Chang, Jianmei
    Yang, Wanfang
    Hou, Ruixia
    Muyey, Daniel Muteb
    Xu, Jing
    Cui, Jiangxia
    Chen, Xiuhua
    Wang, Hongwei
    FRONTIERS IN ONCOLOGY, 2024, 13
  • [7] JAK2, CALR, and MPL mutation spectrum in Japanese patients with myeloproliferative neoplasms
    Shirane, Shuichi
    Araki, Marito
    Morishita, Soji
    Edahiro, Yoko
    Takei, Hiraku
    Yoo, Yongjin
    Choi, Murim
    Sunami, Yoshitaka
    Hironaka, Yumi
    Noguchi, Masaaki
    Koike, Michiaki
    Noda, Naohiro
    Ohsaka, Akimichi
    Komatsu, Norio
    HAEMATOLOGICA, 2015, 100 (02) : E46 - E48
  • [8] Mutant NRAS Q61K is responsible for MAPK pathway activation in the MARIMO cell line and renders these cells independent of the CALR-MPL-JAK2-STAT5 pathway
    Han, Lijuan
    Czech, Julia
    Maurer, Angela
    Bruemmendorf, Tim H.
    Chatain, Nicolas
    Koschmieder, Steffen
    LEUKEMIA, 2018, 32 (09) : 2087 - 2090
  • [9] Co-occurrence of JAK2 V617F and an uncommon CALR del (p. K368fs*51) mutation facilitates JAK2/STAT signaling in polycythemia vera
    Xing, Chong-yun
    Li, Hai-ying
    Wu, Jian-bo
    Gao, Shen-meng
    LEUKEMIA & LYMPHOMA, 2016, 57 (07) : 1743 - 1745
  • [10] CALR, JAK2 and MPL mutation status in Argentinean patients with BCR-ABL1- negative myeloproliferative neoplasms
    Jorgelina Ojeda, Mara
    Margarita Bragos, Irma
    Lucrecia Calvo, Karina
    Marcela Williams, Gladis
    Magdalena Carbonell, Maria
    Flavia Pratti, Arianna
    HEMATOLOGY, 2018, 23 (04) : 208 - 211
12345